Cyclosporin therapy in steroid-dependent nephrotic syndrome

• Published in: Journal of paediatrics and child health Vol. 29; no. 3; p. 188
• Main Authors: Webb, K L, Sargent, P, Burke, J R
• Format: Journal Article
• Language: English
• Published: Australia 01.06.1993
• Subjects: Adolescent; Child; Cyclosporine - therapeutic use; Female; Humans; Kidney - pathology; Male; Nephrotic Syndrome - drug therapy; Nephrotic Syndrome - pathology; Recurrence; Remission Induction; Treatment Outcome
• ISSN: 1034-4810
• DOI: 10.1111/j.1440-1754.1993.tb00484.x

Five children with multiple relapsing steroid-dependent nephrotic syndrome were treated with continuous cyclosporin for periods ranging from 18 to 48 months. Renal biopsy showed mild mesangial proliferation in three of the children and minimal change in two. All children previously had been treated with cyclophosphamide. Cyclosporin was started during remission at 5 mg/kg per day. If a relapse occurred the dose was increased until a trough blood level of 100-250 ng/mL (HPLC) was achieved. In the initial 12 months of treatment, the mean number of relapses decreased from 6.4 +/- 0.54 (s.d.) per annum to 1.6 +/- 1.3 per annum (P < 0.01). Cyclosporin was effective in maintaining long-term remission in four of the five patients. Side effects included hypertrichosis (5) and gum hyperplasia (1). The mean creatinine clearance decreased from 126 +/- 16 to 97 +/- 22 mL/min per 1.73 m2 (P = NS). A renal biopsy in all five patients after 12 months therapy showed no nephrotoxicity. A further biopsy in one patient after 4 years therapy showed interstitial fibrosis. Cyclosporin should be considered in children with steroid-dependent nephrotic syndrome who show signs of steroid toxicity and have only a short remission period after cyclophosphamide. Serial renal biopsies are recommended if prolonged therapy is used.